Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 15, 2004; 10(24): 3590-3596
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3590
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3590
Time | Normal control (n = 6) | I/R + Saline (n = 36) | I/R + aFGF (n = 36) | I/R + aFGF 28-154 (n = 36) |
Before ischemia | 5.83 ± 1.47 | 5.83 ± 1.47 | 5.83 ± 1.47 | 5.83 ± 1.47 |
I/R 30 min | 29.83 ± 3.43b | 23.83 ± 2.78c | 25.50 ± 1.87c | |
I/R 60 min | 39.33 ± 4.32b | 30.33 ± 3.07c | 33.44 ± 5.60c | |
I/R 2 h | 46.16 ± 4.60b | 39.66 ± 3.56c | 40.66 ± 2.73c | |
I/R 6 h | 31.33 ± 3.72b | 25.5 ± 2.16c | 26.00 ± 2.61c | |
I/R 12 h | 62.5 ± 3.08b | 48.50 ± 2.74c | 50.16 ± 3.71c | |
I/R 24 h | 51.66 ± 3.87b | 41.33 ± 2.94c | 42.16 ± 3.31c |
- Citation: Fu XB, Li XK, Wang T, Cheng B, Sheng ZY. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity. World J Gastroenterol 2004; 10(24): 3590-3596
- URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3590.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i24.3590